Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New helper sections were added to the study page (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment header was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the page footer revision label updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:32:36.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor deployment update.
    Difference
    0.1%
    Check dated 2026-06-05T10:07:36.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing v3.5.3, indicating a small version update to the ClinicalTrials.gov page rendering.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.5.2 to v3.5.3, updating the page's metadata.
    Difference
    0.1%
    Check dated 2026-04-30T18:54:00.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T11:12:12.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:49:55.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.